| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2691 |
| Trial ID | NCT04890236 |
| Disease | Diffuse Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Tisagenlecleucel|Kymriah |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Diffuse Large B Cell Lymphoma (DEEP T CELLS) |
| Year | 2022 |
| Country | United States |
| Company sponsor | Emory University |
| Other ID(s) | STUDY00001001|NCI-2020-06380|Winship5085-20|P30CA138292 |
| Cohort 1 | |||||||
|
|||||||